Cardiovascular Applications Research Articles

Last technological advancement in additive manufacturing for cardiovascular applications.

Additive manufacturing (AM) has increasing applications in medicine in recent times. This technology has emerged in cardiovascular medicine as an intelligent system for the improvement of medical devices, the preparation of patient-specific models, and the prototyping of grafts. This review traces the research and development in the production of surgical guides and synthetic grafts for cardiac and vascular applications over the last few years. It also traces the recent widespread use of 3D-printed specific-patient models for cardiovascular surgical interventions. A current view of AM strategies, materials and solutions to improve cardiovascular patient outcomes is also provided.

Modulation of Mitochondrial Bioenergetics by Polydopamine Nanoparticles in Human iPSC-Derived Cardiomyocytes.

Myocardial infarction (MI) leads to the formation of an akinetic scar on the heart muscle causing impairment in cardiac contractility and conductance, leading to cardiac remodeling and heart failure (HF). The current pharmacological approaches for attenuating MI are limited and often come with long-term adverse effects. Therefore, there is an urgent need to develop novel multimodal therapeutics capable of modulating cardiac activity without causing any major adverse effects. In the current study, we have demonstrated the applicability of polydopamine nanoparticles (PDA-NPs) as a bioactive agent that can enhance the contractility and beat propagation of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Treatment of hiPSC-CMs with PDA-NPs demonstrated accumulation of the latter into mitochondria and significantly enhanced time-dependent adenosine triphosphate (ATP) production in these cells, indicating improved mitochondrial bioenergetics. Furthermore, the effect of PDA-NPs on hiPSC-CM activity was evaluated by measuring calcium transients. Treatment with PDA-NPs increased the calcium cycling in hiPSC-CMs in a temporal manner. Our results demonstrated a significant reduction in peak amplitude, transient duration, time to peak, and transient decay time in the PDA-NPs-treated hiPSC-CMs as compared to untreated hiPSC-CMs. Additionally, treatment of isolated perfused rat heart ex vivo with PDA-NPs demonstrated cardiotonic effects on the heart and significantly improved the hemodynamic function, suggesting its potential for enhancing whole heart contractility. Lastly, the gene expression analysis data revealed that PDA-NPs significantly upregulated cardiac-specific genes (ACADM, MYL2, MYC, HCN1, MYL7, GJA5, and PDHA1) demonstrating the ability to modulate genetic expression of cardiomyocytes. Taken together, these findings suggest PDA-NPs capability as a versatile nanomaterial with potential uses in next-generation cardiovascular applications.

Copper-chitosan nanoparticles incorporated PGS/MAO bilayer coatings for potential cardiovascular application

This study aims to develop bilayer copper-chitosan nanoparticles (Cu-Ch NPs) incorporated polyglycerol sebacate (PGS)/ micro-arc oxidation (MAO) (MAO-PGS/Cu-Ch NPs) coating for the cardiovascular application. Moreover, the effects of Cu-Ch NP concentrations (1, 3, and 5 wt%) on the physical, chemical, electrochemical, and biological properties of AZ91 substrate are discussed. Microstructural studies show the successful incorporation of Cu-Ch NPs in the PGS coatings using a simple electrospray process, improving surface wettability and roughness. The results of the potentiodynamic polarization test in phosphate buffer saline (PBS) indicate that the highest corrosion resistance (Icorr = 20 nA/cm2, Ecorr = −1.22 V) is obtained by adding 5 wt% Cu-Ch NPs. NO release evaluation shows while the burst release occurrs in the early hours, the extended-release happens after 12 h. Moreover, the increase in the Cu-Ch NP concentration reduces the platelet adhesion, showing the appropriate hemocompatibility of coatings. In addition, the attachment and proliferation of human umbilical vein endothelial cells (HUVECs) improve by increasing the concentration of Cu-Ch NPs within the bilayer coating. Taken together, MAO-PGS/Cu-Ch NPs coating with appropriate surface properties, corrosion resistance, cytocompatibility and hemocompatibility, demonstrates the potential application for cardiovascular implants.

Assessment of the Anti-Thrombogenic Activity of Polyurethane Starch Composites.

The increasing morbidity and mortality of patients due to post-surgery complications of coronary artery bypass grafts (CABPG) are related to blood–material interactions. Thus, the characterization of the thrombogenicity of the biomaterial for cardiovascular devices is of particular interest. This research evaluated the anti-thrombogenic activity of polyurethanes–starch composites. We previously synthesized polyurethane matrices that were obtained from polycaprolactone diol (PCL), polyethylene glycol (PEG), pentaerythritol (PE), and isophorone diisocyanate (IPDI). In addition, potato starch (AL-N) and zwitterionic starch (AL-Z) were added as fillers. The anti-thrombogenic property was characterized by the clot formation time, platelet adhesion, protein absorption, TAT complex levels, and hemolysis. Additionally, we evaluated the cell viability of the endothelial and smooth muscle cells. Statically significant differences among the polyurethane matrices (P1, P2, and P3) were found for protein absorption and the blood clotting time without fillers. The polyurethanes composites with AL-Z presented an improvement in the anti-thrombogenic property. On the other hand, the composites with AL-Z reduced the viability of the endothelial cells and did not significantly affect the AoSCM (except for P1, which increased). These results classify these biomaterials as inert; therefore, they can be used for cardiovascular applications.

Corrosion, mechanical and biological properties of biodegradable WE43 alloy modified by Al ion implantation

A high-energy metal vapor vacuum arc (MEVVA) ion source was used to implant aluminum (Al) ions into the WE43 alloy (Al-WE43) at a dose of 1 × 1016 ions·cm−2, and the structural composition, mechanical properties, corrosion resistance, and biocompatibility of the alloy before and after implantation were systematically studied. The results showed that an Al2O3/Al thin film was formed on the surface of the WE43 alloy after Al ion implantation, and the dense film caused the corrosion current density (Icorr) of the alloy to decrease from 140.2 ± 9.3 to 17.9 ± 6.1 μA⋅cm−2. Nanoindentation experiments revealed that the elastic model (EIT) and nano-hardness (HIT) of the Al-WE43 alloy were significantly improved due to the surface lattice distortion caused by Al ion implantation. A diluted extract of the Al-WE43 alloy showed higher cell activity, anti-hemolysis and anti-coagulation properties than that of the WE43 alloy. In general, the Al-WE43 alloy can be considered as a promising biodegradable metallic material for cardiovascular stent applications.

Mechanical properties and biocorrosion behaviour of as-cast Zn-xCu-Sr alloys for cardiovascular bioabsorbable devices

ABSTRACT In this study, the mechanical and biocorrosion behavior of as-cast Zn-xCu-0.1Sr (x = 1, 2, and 3wt%) alloys for potential application was studied. The microstructure, mechanical properties, and in vitro degradation of Zn-xCu-0.1Sr alloys were investigated. The results show that as Cu content increased from 1.0 to 3.0wt%, the number of CuZn5 phases increased and the average grain size of CuZn5 phases increased from 6.96 μm to 10.92 μm. The 2wt% addition of Cu resulted in the best mechanical properties with 129.4 MPa in ultimate tensile strength and 108.4 MPa in yield strength. Furthermore, the higher corrosion rate was experienced in the alloys with higher Cu content after immersion. Zn-xCu-0.1Sr alloys all presented appropriate in vitro degradation rates in a basically uniform degradation mode. The strength, ductility and biocorrosion property exhibited by the Zn-2Cu-0.1Sr alloy compositions make it a promising candidate for cardiovascular stent applications.

Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies.

Antithrombotic and thrombolytic therapies are used to prevent, treat, and remove blood clots in various clinical settings, from emergent to prophylactic. While ubiquitous in their healthcare application, short half-lives, off-target effects, overdosing complications, and patient compliance continue to be major liabilities to the utility of these agents. Biomaterials-enabled strategies have the potential to comprehensively address these limitations by creating technologies that are more precise, durable, and safe in their antithrombotic action. In this review, we discuss the state of the art in anticoagulant and thrombolytic biomaterials, covering the nano to macro length scales. We emphasize current methods of formulation, discuss how material properties affect controlled release kinetics, and summarize modern mechanisms of clot-specific drug targeting. The preclinical efficacy of these technologies in an array of cardiovascular applications, including stroke, pulmonary embolism, myocardial infarction, and blood contacting devices, is summarized and performance contrasted. While significant advances have already been made, ongoing development efforts look to deliver bioresponsive "smart" biomaterials that will open new precision medicine opportunities in cardiology.

Hemocompatibility of micropatterned biomaterial surfaces is dependent on topographical feature size.

Small-diameter synthetic vascular grafts that have improved hemocompatibility and patency remain an unmet clinical need due to thrombosis. A surface modification that has potential to attenuate these failure mechanisms while promoting an endothelial layer is the micropatterning of luminal surfaces. Anisotropic features have been shown to downregulate smooth muscle cell proliferation, direct endothelial migration, and attenuate platelet adhesion and activation. However, the effect of micropatterning feature size and orientation relative to whole blood flow has yet to be investigated within a systematic study. In this work, hemocompatibility of micropattern grating sizes of 2, 5, and 10 µm were investigated. The thrombogenicity of the micropattern surface modifications were characterized by quantifying FXIIa activity, fibrin formation, and static platelet adhesion in vitro. Additionally, dynamic platelet attachment and end-point fibrin formation were quantified using an established, flowing whole blood ex vivo non-human primate shunt model without antiplatelet or anticoagulant therapies. We observed a higher trend in platelet attachment and significantly increased fibrin formation for larger features. We then investigated the orientation of 2 µm gratings relative to whole blood flow and found no significant differences between the various orientations for platelet attachment, rate of linear platelet attachment, or end-point fibrin formation. MicroCT analysis of micropatterned grafts was utilized to quantify luminal patency. This work is a significant step in the development of novel synthetic biomaterials with improved understanding of hemocompatibility for use in cardiovascular applications.

Evolution of commercially pure titanium/heparin/poly (ethylene glycol) substrate with improved biocompatibility for cardiovascular device applications

ABSTRACT The present work focuses on the evolution of alkali-modified commercially pure titanium (cpTi)-heparin-polyethylene glycol (PEG; 20,000 MW) substrate via a layer-by-layer physical adsorption process. Physicochemical and in-vitro biological properties of developed samples were studied analytically before and after heat treatment. A nanoporous network after alkali treatment and a homogenous polymer layer over the alkali-treated cpTi-heparin surface was revealed by physicochemical characterization. Heparin stability was monitored and showed good stability with PEG coating in PBS (pH=7.4) for 24 h. The thrombin activity was found to be reduced with a PEG-coated heparin-loaded cpTi surface. The nanoporous structure holding −OH groups showed better biocompatibility. The modified cpTi surfaces exhibited good antibacterial performance against Staphylococcus aureus. Heparin toxicity has been estimated to determine the effect of heparin concentration in interstitial cell lines. All the lower concentrations of heparin showed good cell viability. Therefore, the modified cpTi substrates are promising candidates for cardiovascular device applications.

Sequential immobilization of sirolimus and polyethylene glycol on ultrafine-grained commercial pure titanium for cardiovascular stent application

Sequential immobilization of sirolimus and polyethylene glycol on ultrafine-grained commercial pure titanium for cardiovascular stent application

A high-hydrophilic Cu2O-TiO2/Ti2O3/TiO coating on Ti-5Cu alloy: Perfect antibacterial property and rapid endothelialization potential

In order to make novel antibacterial Ti-Cu alloy more suitable for cardiovascular implant application, a Cu-containing oxide coating was manufactured on Ti-Cu alloy by plasma-enhanced oxidation deposition in plasma enhanced chemical vapor deposition (PECVD) equipment to further improve the antibacterial ability and the surface bioactivity. The results of X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM) and water contact angle indicated that a sustainably high-hydrophilic Cu2O-TiO2/Ti2O3/TiO coating with nano-morphology on Ti-5Cu was successfully constructed. The corrosion performance results showed that the coating enhanced the corrosion resistance while releasing more Cu2+, compared with Ti-5Cu. Antibacterial tests confirmed the perfect antibacterial property of the coating (R≥99.9%), superior to Ti-Cu alloy (R>90%). More delightfully, it was observed by phalloidin-FITC and DAPI staining that the coating improved the early adhesion of HUVEC cells mainly due to strong hydrophilicity and nano-morphology. It was demonstrated that the extract of the coated sample significantly promoted proliferation (RGR=112%-138% after cultivation for 1 to 3days) and migration of HUVEC cells due to the appropriate Cu2+ release concentration. Hemolysis assay and platelet adhesion results showed that the coating had excellent blood compatibility. All results suggested that the coating on Ti-Cu alloy might be a promising surface with the perfect antibacterial ability, blood compatibility and evident promoting endothelialization ability for the cardiovascular application.

Functionality of Flexible Pressure Sensors in Cardiovascular Health Monitoring: A Review.

As the highest percentage of global mortality is caused by several cardiovascular diseases (CVD), maintenance and monitoring of a healthy cardiovascular condition have become the primary concern of each and every individual. Simultaneously, recent progress and advances in wearable pressure sensor technology have provided many pathways to monitor and detect underlying cardiovascular illness in terms of irregularities in heart rate, blood pressure, and blood oxygen saturation. These pressure sensors can be comfortably attached onto human skin or can be implanted on the surface of vascular grafts for uninterrupted monitoring of arterial blood pressure. While the traditional monitoring systems are time-consuming, expensive, and not user-friendly, flexible sensor technology has emerged as a promising and dynamic practice to collect important health information at a comparatively low cost in a reliable and user-friendly way. This Review explores the importance and necessity of cardiovascular health monitoring while emphasizing the role of flexible pressure sensors in monitoring patients' health conditions to avoid adverse effects. A comprehensive discussion on the current research progress along with the real-time impact and accessibility of pressure sensors developed for cardiovascular health monitoring applications has been provided.

A Biocompatibility Study of Plasma Nanocoatings onto Cobalt Chromium L605 Alloy for Cardiovascular Stent Applications.

The objective of this study was to evaluate the biocompatibility of trimethylsilane (TMS) plasma nanocoatings modified with NH3/O2 (2:1 molar ratio) plasma post-treatment onto cobalt chromium (CoCr) L605 alloy coupons and stents for cardiovascular stent applications. Biocompatibility of plasma nanocoatings was evaluated by coating adhesion, corrosion behavior, ion releasing, cytotoxicity, and cell proliferation. Surface chemistry and wettability were studied to understand effects of surface properties on biocompatibility. Results show that NH3/O2 post-treated TMS plasma nanocoatings are hydrophilic with water contact angle of 48.5° and have a typical surface composition of O (39.39 at.%), Si (31.92 at.%), C (24.12 at.%), and N (2.77 at.%). The plasma nanocoatings were conformal to substrate surface topography and had excellent adhesion to the alloy substrates, as assessed by tape test (ASTM D3359), and showed no cracking or peeling off L605 stent surfaces after dilation. The plasma nanocoatings also improve the corrosion resistance of CoCr L605 alloy by increasing corrosion potential and decreasing corrosion rates with no pitting corrosion and no mineral adsorption layer. Ion releasing test revealed that Co, Cr, and Ni ion concentrations were reduced by 64–79%, 67–69%, and 57–72%, respectively, in the plasma-nanocoated L605 samples as compared to uncoated L605 control samples. The plasma nanocoatings showed no sign of cytotoxicity from the test results according to ISO 10993-05 and 10993-12. Seven-day cell culture demonstrated that, in comparison with the uncoated L605 control surfaces, the plasma nanocoating surfaces showed 62 ± 7.3% decrease in porcine coronary artery smooth muscle cells (PCASMCs) density and had comparable density of porcine coronary artery endothelial cells (PCAECs). These results suggest that TMS plasma nanocoatings with NH3/O2 plasma post-treatment possess the desired biocompatibility for stent applications and support the hypothesis that nanocoated stents could be very effective for in-stent restenosis prevention.

A Review on Novel Channel Materials for Particle Image Velocimetry Measurements-Usability of Hydrogels in Cardiovascular Applications.

Particle image velocimetry (PIV) is an optical and contactless measurement method for analyzing fluid blood dynamics in cardiovascular research. The main challenge to visualization investigated in the current research was matching the channel material’s index of refraction (IOR) to that of the fluid. Silicone is typically used as a channel material for these applications, so optical matching cannot be proven. This review considers hydrogel as a new PIV channel material for IOR matching. The advantages of hydrogels are their optical and mechanical properties. Hydrogels swell more than 90 vol% when hydrated in an aqueous solution and have an elastic behavior. This paper aimed to review single, double, and triple networks and nanocomposite hydrogels with suitable optical and mechanical properties to be used as PIV channel material, with a focus on cardiovascular applications. The properties are summarized in seven hydrogel groups: PAMPS, PAA, PVA, PAAm, PEG and PEO, PSA, and PNIPA. The reliability of the optical properties is related to low IORs, which allow higher light transmission. On the other hand, elastic modulus, tensile/compressive stress, and nominal tensile/compressive strain are higher for multiple-cross-linked and nanocomposite hydrogels than single mono-cross-linked gels. This review describes methods for measuring optical and mechanical properties, e.g., refractometry and mechanical testing.

Influence of Starch on the Structure-Properties Relationship in Polyethylene Glycol/Polycaprolactone Diol Polyurethanes.

Improvements in the antithrombogenicity activity of biomaterials for cardiovascular applications are necessary to meet the demand for vascular grafts in the world. Zwitterionic compounds tend to be used due to their anti-fouling properties, which reduce platelet adhesions and protein absorptions. Therefore, in this research, potato starch (AL-N) and zwitterionic starch (AL-Z) (obtained by Williamson etherification) were included as fillers in polyurethane (PU) matrices from polycaprolactone diol (PCL), polyethylene glycol (PEG), pentaerythritol (PE) and isophorone diisocyanate (IPDI) in order to study their effect in terms of their physicochemical, mechanical and thermal properties. We conducted our evaluation using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), contact angle analysis, swelling behavior, thermogravimetric analysis (TGA), tensile/strain analysis, scanning electron microscopy equipped with energy dispersive X-ray spectroscopy (SEM-EDS), dynamic mechanic analysis (DMA), differential scanning calorimetry (DSC), and X-ray diffraction (XRD). The results showed that AL-N and AL-Z modified these properties, where AL-N improved tensile strength, and AL-Z increased the hydrophilicity of polyurethanes matrices; additionally, AL-N had interactions with the soft segments, and AL-Z had interactions with the hard segments. Finally, both fillers reduced the degree of crystallinity and did not affect the thermal stability of polyurethanes.

Multilayer self-assembled kappa carrageenan/ chitosan: Heparin coating on Mg alloys for improving blood compatibility

The study aims to develop a layer-by-layer (LbL) self-assembled coating of Kappa carrageenan (KC) and heparin-loaded chitosan nanoparticles on the AZ91 alloy modified using micro-arc oxidation (MAO) to control its high corrosion rate and improve the hemocompatibility. In this regard, after the MAO process, polyethylene imine (PEI) coating was initially coated on the AZ91 samples. Heparin was loaded on chitosan nanoparticles (chitosan: heparin) with an average size of 55–130 nm. Afterward LBL self-assembled process was performed to deposit subsequent Chitosan: heparin and KC layers on MAO modified AZ91 (KC/Chitosan: heparin). The LbL process was repeated for 10,20, and 30 layers to get a uniform coating with desired electrochemical and biological properties. The electrochemical performance of the samples in phosphate-buffered saline (PBS, pH= 7.4) showed a significant improvement in the corrosion resistance of AZ91 samples after a two-step MAO and 30-layer LbL coating. Moreover, the heparin release from the multilayered coated samples was enhanced by increasing the number of layers. Finally, the determination of blood cell count (red blood cells, white blood cells, and platelets) and platelet adhesion indicated that controlled release of heparin from the coating resulted in a significant improvement of hemocompatibility. Overall, this multilayer KC/Chitosan: heparin coating with significant corrosion resistivity and hemocompatibility could have the potential for cardiovascular stent applications.

A multi-functional MgF2/polydopamine/hyaluronan-astaxanthin coating on the biodegradable ZE21B alloy with better corrosion resistance and biocompatibility for cardiovascular application

The cardiovascular diseases (CVD) continue to be the major threat to global public health over the years, while one of the effective methods to treat CVD is stent intervention. Biomedical magnesium (Mg) alloys have great potential applications in cardiovascular stents benefit from their excellent biodegradability and absorbability. However, excessive degradation rate and the delayed surface endothelialization still limit their further application. In this study, we modified a Mg-Zn-Y-Nd alloy (ZE21B) by preparing MgF2 as the corrosion resistance layer, the dopamine polymer film (PDA) as the bonding layer, and hyaluronic acid (HA) loaded astaxanthin (ASTA) as an important layer to directing the cardiovascular cells fate. The electrochemical test results showed that the MgF2/PDA/HA-ASTA coating improved the corrosion resistance of ZE21B. The cytocompatibility experiments also demonstrated that this novel composite coating also selectively promoted endothelial cells proliferation, inhibited hyperproliferation of smooth muscle cells and adhesion of macrophages. Compared with the HA-loaded rapamycin (RAPA) coating, our MgF2/PDA/HA-ASTA coating showed better blood compatibility and cytocompatibility, indicating stronger multi-functions for the ZE21B alloy on cardiovascular application.

PEGylated Gold Nanoparticle Toxicity in Cardiomyocytes: Assessment of Size, Concentration, and Time Dependency.

Gold Nanoparticles (GNPs) have shown promising capabilities for use in many in-vivo applications such as gene and drug delivery, photothermal ablation of tumors, and tracking in many imaging modalities. Yet GNPs have thus far had limited use in cardiovascular medicine. Polyethylene glycol functionalized (PEGylated) GNPs have been extensively studied in a wide array of in vitro and in vivo models with results showing no apparent toxicity, but to our knowledge an investigation has never been performed to determine direct cardiomyocyte toxicity. In this study, we assessed if PEGylated GNPs exhibited direct toxicity to a primary culture of neonatal rat cardiomyocytes in order to establish PEGylated GNPs for potential future use in cardiovascular medicine applications. We present novel results that demonstrate both a particle size and concentration dependent relationship on cell viability. Cell viability was found to be significantly enhanced for many concentrations and sizes as compared to the control and increased linearly as a function of particle diameter. Additionally, viability increased in a parabolically dependent manner as a function of decreasing particle concentration. These new results could advance understanding of nanoparticle-cell interactions and lead to the development of new applications involving the use of gold nanoparticles in cardiovascular medicine.

Micro/nanoscale surface engineering to enhance hemocompatibility and reduce bacterial adhesion for cardiovascular implants

Precise engineering of surface properties is essential for improving bio/hemocompatibility of medical implants. In this study, potential of electrospraying (ES) as a coating method to control surface properties was evaluated in vitro. Poly (lactic acid) was coated on 316 L stainless steel plates by ES and spin-coating methods. Surface topography and morphology were studied using confocal and scanning electron microscope (SEM), respectively. Surface hydrophobicity and mechanical properties were investigated by contact angle and nanoindentation tests. Hemocompatibility of samples evaluated using protein adsorption, hemolysis, blood coagulation, complement system and leukocyte activation experiments. Platelet response to the coatings was examined using LDH assay, SEM and ELISA tests. Cell viability studies performed on human endothelial cells using MTT assay and SEM after 1, 4 and 7 days. SEM was used to consider formation of pseudomonas aeruginosa biofilms on the coatings. The results showed that ES increased hydrophobicity (122֯ vs 90֯) and surface roughness (2 μm vs 1.2 μm) but reduced surface stiffness (200 MPa vs 10800 MPa) in comparison to spin-coated samples. ES-coatings had microbead/nanofiber morphology while spin-coated samples had micro/nanoporous structure. Importantly, an almost confluent layer of endothelial cells was observed on ES-coated samples after 4 days in contrast to spin-coated ones. Various blood experiments revealed both coatings were hemocompatible and there was no significant difference among ES and spin-coated samples. Furthermore, ES-coated samples showed significantly lower propensity for biofilm formation. In conclusion, in vitro results revealed potential of ES to engineer different coating properties including hemo/biocompatibility and biofilm resistance for cardiovascular implants applications.

Current Status and Outlook of Temporary Implants (Magnesium/Zinc) in Cardiovascular Applications

Medical application materials must meet multiple requirements, and the designed material must mimic the structure, shape. and support the formation of the replacing tissue. Magnesium (Mg) and Zinc alloys (Zn), as a “smart” biodegradable material and as “the green engineering material in the 21st century”, have become an outstanding implant material due to their natural degradability, smart biocompatibility, and desirable mechanical properties. Magnesium and Zinc are recognized as the next generation of cardiovascular stents and bioresorbable scaffolds. At the same time, improving the properties and corrosion resistance of these alloys is an urgent challenge. particularly to promote the application of magnesium alloys. A relatively fast deterioration rate of magnesium-based materials generally results in premature mechanical integrity compromise and local hydrogen build-up, resulting in restricted applicability. This review article aims to give a comprehensive comparison between Zn-based alloys and Mg-based alloys, focusing primarily on degradation and biocompatibility for cardiovascular applications. The recent clinical trials using these biodegradable metals have also been addressed.